Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
NATIONAL UNIVERSITY CORPORATION has floated a tender for A Sebelipase Alfa (Genetical Recombinaion, 20 10/1Vial) 138 Vials, Eculizumab (Genetical Recombination, 300 301Vial) 1 Vials, Nushinersen Sodium (121Vial) 1 Vials, Cetuximab Sarotalocan Sodi.... The project location is Japan and the tender is closing on 31 Mar 2025. The tender notice number is , while the TOT Ref Number is 114125195. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Japan
Summary : A Sebelipase Alfa (Genetical Recombinaion, 20 10/1Vial) 138 Vials, Eculizumab (Genetical Recombination, 300 301Vial) 1 Vials, Nushinersen Sodium (121Vial) 1 Vials, Cetuximab Sarotalocan Sodi...
Deadline : 31 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 114125195
Document Ref. No. :
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
A Sebelipase Alfa (Genetical Recombinaion, 20 10/1vial) 138 vials, Eculizumab (Genetical Recombination, 300 301vial) 1 vials, Nushinersen Sodium (121vial) 1 vials, Cetuximab Sarotalocan Sodi...
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of disbursement of the procuring entity : Hiromitsu Nakajima, President, Tottori University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Sebelipase Alfa (Genetical Recombinaion, 20㎎ 10㎖/1vial) 138 vials
B Eculizumab (Genetical Recombination, 300㎎ 30㎖/1vial) 1 vials
C Nushinersen Sodium (12㎎/1vial) 1 vials
D Cetuximab Sarotalocan Sodium (Genetical Recombination, 250㎎ 50㎖/1vial) 50 vials
E Polatuzumab Vedotin (Genetical Recombination, 140㎎/1vial) 6 vials
F Polatuzumab Vedotin (Genetical Recombination, 30㎎/1vial) 439 vials
G Pabinafusp Alfa (Genetical Recombination, 10㎎/1vial) 59 vials
H Satralizumab (Genetical Recombination, 120㎎ 1㎖/1vial) 6 vials
I Faricimab (Genetical Recombination, 120㎎ 0.24㎖/1vial) 408 vials
J Axicabtagene ciloleucel Once
K Onasemnogene abeparvovec Once
⑷ Delivery period : From 1 May, 2025 through 31 March, 2026
⑸ Delivery place : Department of Hospital Pharmacy, Tottori University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 and 6 of the Regulation concerning the Contract for Tottori University Furthermore, minors, Person under Conservators...
Documents
Procurement Documents for Japan
Access a comprehensive library of standard procurement documents specific to Japan. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Japan
Want To Bid in This Tender?
Get Local Agent Support in Japan and 60 More Countries.
View Tenders By
Sign in with Google